Down-regulation of miR-4500 promoted non-small cell lung cancer growth

Cellular Physiology and Biochemistry

Volumn 34, Issue 4, 2014, Pages 1166-1174

  Zhang, Lei ^a   Qian, Jianjun ^a   Qiang, Yong ^a   Huang, Hairong ^a   Wang, Changtian ^a   Li, Demin ^a   Xu, Biao ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

LIN28B; MiR 4500; NRAS; NSCLC

Indexed keywords

MICRORNA; MICRORNA 4500; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; DOWN REGULATION; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; LIN28B GENE; MAJOR CLINICAL STUDY; MTT ASSAY; NON SMALL CELL LUNG CANCER; ONCOGENE; ONCOGENE N RAS; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LUNG TUMOR; SURVIVAL RATE; TUMOR CELL LINE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICRORNAS; SURVIVAL RATE;

EID: 84908610332     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366329     Document Type: Article

References (31)

1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008;83:584-594.
2. Ramalingam SS, Owonikoko TK, Khuri FR: Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin 2011;61:91-112.
3. Lung cancer: A global scourge. Lancet 2013;382:659.
4. Wen C, Dehnel T: China wrestles with lung cancer. Lancet Oncol 2011;12:15.
5. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I: Recent cancer survival in europe: A 2000-02 period analysis of eurocare-4 data. Lancet Oncol 2007;8:784-796.
6. Ambros V: The functions of animal micrornas. Nature 2004;431:350-355.
7. Garzon R, Calin GA, Croce CM: Micrornas in cancer. Annu Rev Med 2009;60:167-179.
8. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microrna molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198.
9. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Li KC, Chen JJ, Yang PC: Microrna signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57.
10. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG: Microrna classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009;69:5776-5783.
11. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC: Mir-21 is an egfr-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009;106:12085-12090.
12. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S: Evaluation of microrna expression profiles that may predict recurrence of localized stage i non-small cell lung cancer after surgical resection. Cancer Res 2010;70:36-45.
13. Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, Lagoo AS, Lugar PL, Mann KP, Flowers CR, Bernal-Mizrachi L, Naresh KN, Evens AM, Gordon LI, Luftig M, Friedman DR, Weinberg JB, Thompson MA, Gill JI, Liu Q, How T, Grubor V, Gao Y, Patel A, Wu H, Zhu J, Blobe GC, Lipsky PE, Chadburn A, Dave SS: Deep sequencing of the small rna transcriptome of normal and malignant human b cells identifies hundreds of novel micrornas. Blood 2010;116:e118-127.
14. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ: Mirbase: Microrna sequences, targets and gene nomenclature. Nucleic Acids Res 2006;34:D140-144.
15. Madison BB, Liu Q, Zhong X, Hahn CM, Lin N, Emmett MJ, Stanger BZ, Lee JS, Rustgi AK: Lin28b promotes growth and tumorigenesis of the intestinal epithelium via let-7. Genes Dev 2013;27:2233-2245.
16. Malumbres M, Barbacid M: Ras oncogenes: The first 30 years. Nat Rev Cancer 2003;3:459-465.
17. Mansi L, Viel E, Curtit E, Medioni J, Le Tourneau C: [targeting the ras signalling pathway in cancer]. Bull Cancer 2011;98:1019-1028.
18. Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D: Ras oncogenes: Weaving a tumorigenic web. Nat Rev Cancer 2011;11:761-774.
19. Shimizu K, Goldfarb M, Perucho M, Wigler M: Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line. Proc Natl Acad Sci U S A 1983;80:383-387.
20. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhuang SM, Zheng L, Liang A, Tao W, Cao X: Identification of mirnomes in human liver and hepatocellular carcinoma reveals mir-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011;19:232-243.
21. van Meerloo J, Kaspers GJ, Cloos J: Cell sensitivity assays: The mtt assay. Methods Mol Biol 2011;731:237-245.
22. Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X: Microrna-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 2011;286:36677-36685.
23. Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji Y, Wang J, Zhao H, Han ZC: Microrna-124 suppresses breast cancer cell growth and motility by targeting cd151. Cell Physiol Biochem 2013;31:823-832.
24. Lu J, Wen M, Huang Y, He X, Wang Y, Wu Q, Li Z, Castellanos-Martin A, Abad M, Cruz-Hernandez JJ, Rodriguez CA, Perez-Losada J, Mao JH, Wei G: C2orf40 suppresses breast cancer cell proliferation and invasion through modulating expression of m phase cell cycle genes. Epigenetics 2013;8:571-583.
25. Lewis B P, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005;120:15-20.
26. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mrnas are conserved targets of micrornas. Genome Res 2009;19:92-105.
27. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim L P, Bartel DP: Microrna targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 2007;27:91-105.
28. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP: Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other micrornas. Nat Struct Mol Biol 2011;18:1139-1146.
29. Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF, Atkins JF: A dual-luciferase reporter system for studying recoding signals. RNA 1998;4:479-486.
30. Chang TC, Zeitels LR, Hwang HW, Chivukula RR, Wentzel EA, Dews M, Jung J, Gao P, Dang CV, Beer MA, Thomas-Tikhonenko A, Mendell JT: Lin-28b transactivation is necessary for myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A 2009;106:3384-3389.
31. Wang X, Zhao X, Gao P, Wu M: C-myc modulates microrna processing via the transcriptional regulation of drosha. Sci Rep 2013;3:1942.